ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,633.91
      0.00%
      US Tech 100
      20,122.00
      0.02%
      Dow Jones
      39,721.36
      0.00%
      Brent Oil
      84.515
      -0.63%
      Bitcoin
      58,751.78
      1.72%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Hutchmed (china) Limited (HCM)

      7. Hutchmed (china) Limited (HCM) News

      HCM

      Hutchmed (china) (HCM)

      Hutchmed (china) Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:HCM
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      12:30PMiHub NewswireFeaturedECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch
      02/28/20236:43AMAlliance NewsAlliance NewsHutchmed expects revenue climb from oncology, immunology divisionLSE:HCMHutchmed (china) Limited
      02/28/20233:30AMUK RegulatoryHutchmed (China) Limited 2022 Full Year Results and Business UpdatesLSE:HCMHutchmed (china) Limited
      02/27/20236:11AMAlliance NewsAlliance NewsHutchmed completes patient enrolment for trial testing cancer therapyLSE:HCMHutchmed (china) Limited
      02/27/20235:00AMRNS Non-RegulatoryHutchmed (China) Limited Enrollment Completed in Phase 2 Amdizalisib trialLSE:HCMHutchmed (china) Limited
      01/31/20233:30AMUK RegulatoryHutchmed (China) Limited Notice of ResultsLSE:HCMHutchmed (china) Limited
      01/23/20234:05AMDow Jones NewsHutchMed (China) to Receive Up to $1.13 Billion on Fruquintinib Licensing AgreementLSE:HCMHutchmed (china) Limited
      01/23/20234:01AMAlliance NewsAlliance NewsHutchmed signs drug licensing deal with Takeda for sales outside ChinaLSE:HCMHutchmed (china) Limited
      01/23/20233:00AMUK RegulatoryHutchmed (China) Limited License to Takeda for Fruquintinib outside ChinaLSE:HCMHutchmed (china) Limited
      01/18/20232:03PMAlliance NewsAlliance NewsTRADING UPDATES: Galileo confirms gold zone; Spectral hails resultsLSE:HCMHutchmed (china) Limited
      01/18/20239:30AMUK RegulatoryHutchmed (China) Limited Inclusion of ORPATHYS in NRDL in ChinaLSE:HCMHutchmed (china) Limited
      01/03/20235:28AMAlliance NewsAlliance NewsHutchmed completes patient enrolment for ITP clinical trial in ChinaLSE:HCMHutchmed (china) Limited
      01/03/20233:30AMRNS Non-RegulatoryHutchmed (China) Limited Enrollment Completed in Phase 3 TrialLSE:HCMHutchmed (china) Limited
      12/30/20223:30AMUK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:HCMHutchmed (china) Limited
      12/19/20222:29PMAlliance NewsAlliance NewsTRADING UPDATES: Tekcapital's MicroSalt plans IPO in 2023LSE:HCMHutchmed (china) Limited
      12/19/20225:00AMRNS Non-RegulatoryHutchmed (China) Limited FDA NDA Rolling Submission for FruquintinibLSE:HCMHutchmed (china) Limited
      11/15/20225:52AMAlliance NewsAlliance NewsHutchmed China to shift strategy toward advanced assets in pipelineLSE:HCMHutchmed (china) Limited
      11/15/20222:00AMUK RegulatoryHutchmed (China) Limited HUTCHMED Announces Strategy UpdateLSE:HCMHutchmed (china) Limited
      11/14/20229:20AMAlliance NewsAlliance NewsIN BRIEF: Hutchmed sees positive results for gastric cancer drugLSE:HCMHutchmed (china) Limited
      11/14/20225:27AMAlliance NewsAlliance NewsAIM WINNERS & LOSERS: Hutchmed up on positive results for cancer drugLSE:HCMHutchmed (china) Limited
      11/14/20222:00AMUK RegulatoryHutchmed (China) Limited Positive Topline Phase 3 Result in FruquintinibLSE:HCMHutchmed (china) Limited
      10/27/20229:27AMAlliance NewsAlliance NewsIN BRIEF: Hutchmed begins phase II/III trial of fruquintinibLSE:HCMHutchmed (china) Limited
      10/27/20227:30AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase 2/3 Trial of FruquintinibLSE:HCMHutchmed (china) Limited
      10/21/20224:30AMUK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPLSE:HCMHutchmed (china) Limited
      10/10/20225:24AMAlliance NewsAlliance NewsHutchmed begins sovleplenib trial for anaemia treatment in ChinaLSE:HCMHutchmed (china) Limited
      10/10/20224:30AMRNS Non-RegulatoryHutchmed (China) Limited Phase II/III Trial of Sovleplenib for in ChinaLSE:HCMHutchmed (china) Limited
      09/30/20224:30AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
      09/14/20226:00AMUK RegulatoryHutchmed (China) Limited Share Option Scheme and Long Term Incentive PlanLSE:HCMHutchmed (china) Limited
      09/08/20226:02AMAlliance NewsAlliance NewsHutchmed posts positive results for CRC cancer treatmentLSE:HCMHutchmed (china) Limited
       Showing the most relevant articles for your search:LSE:HCM

      Your Recent History

      BITMOT
      844835
      Romania Tf 2,875% Mz29 Eur
      CSE
      HTRC
      High Tide Resources
      Delayed Upgrade Clock